Account
Express Scripts Holding Co. (ESRX) said Monday its first-quarter earnings rose 39%, fueled by last year's Medco Health Solutions deal, and the company slightly increased its full-year earnings outlook.St. Louis-based Express Scripts added three cents to its per-share earnings guidance for 2013, citing expected improvements in gross profits over the balance of the year. The pharmacy-benefit manager's adjusted earnings in the recent quarter, which exclude costs pegged to the Medco deal, came in slightly ahead of Wall Street expectations.Shares climbed 1.7% to $59.42 in after-hours trading. The stock is up about 8% on the year through Monday's close, although it has yet to recover from an early November warning that Wall Street expectations for 2013 looked too high.The company at the time blamed a weak business climate and challenging unemployment outlook, which can affect the volume of prescriptions it handles. But Express Scripts struck a more upbeat tone on its fourth-quarter call in F...
Express Scripts Holding Co (NASDAQ:ESRX) on Tuesday raised its full-year earnings forecast, citing a strong second quarter, increased use of more profitable generic ...
Ending months of costly sparring, Walgreen (NYSE:WAG) inked a multi-year pharmacy benefits network agreement on Thursday with Express Scripts (NASDAQ:ESRX), sending ...
Express Scripts Holding Co.'s (ESRX) first-quarter earnings fell 18%, pressured by costs tied to the recent acquisition of fellow pharmacy-benefit manager Medco Heal...
After almost a year of investigating, the U.S. Federal Trade Commission gave a green light to Express Scripts’ (NASDAQ:ESRX) $29.1 billion takeover of Medco Health S...
Express Scripts Inc. (ESRX) has had a smooth transition away from its relationship with Walgreen Co . (WAG), which left the pharmacy-benefit manager's network on Jan...
Express Scripts (NASDAQ:ESRX) unveiled a $29.1 billion agreement on Thursday to take over rival Medco Health Solutions (NYSE:MHS) in a deal that would create the ind...
Express Scripts (NASDAQ:ESRX) revealed late Tuesday a stronger-than-expected 47% increase in fourth-quarter profit, fueled by higher sales and milder expenses, thoug...
Express Scripts pays $4.68B for deal.
Express Scripts Holding Co. (ESRX) Chief Executive George Paz's compensation rose 50% in value last year, a year in which his company wrapped up a $29.1 billion acqu...
Pharmacy-benefit manager Express Scripts Holding Co. (ESRX) reported a 74% surge in fourth-quarter earnings, helped by a major acquisition, while forecasting 2013 ea...
Express Scripts (NASDAQ:ESRX) reported on Monday a fourth-quarter profit that leaped 75% on higher revenue.Net income for the period was $511 million, compared to $2...
Express Scripts Holding Co.'s (ESRX) clients have "unprecedented concerns" about the U.S. economy that, coupled with pressure on individual patients, is weighing on ...
Express Scripts Holding Co.'s (ESRX) third-quarter earnings rose 21%, helped by the pharmacy-benefit manager's purchase of Medco Health Solutions earlier this year, ...
The U.S. Department of Defense's Tricare health plan has decided it won't let its nearly 10 million beneficiaries who get drug coverage through Express Scripts Holdi...
Express Scripts Holding Co.'s (ESRX) second-quarter earnings fell 49% as the pharmacy-benefit manager absorbed acquisition costs, but results topped Wall Street expe...
